Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.37 Analyst target: $4.00 Upside: 990.81%
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
See the full interactive analysis & chart →Informational only — not investment advice.